News
Mark Joseph Enyedy currently works at ImmunoGen, Inc., as President & Chief Executive Officer, BioMarin Pharmaceutical, Inc., as Independent Director from 2023, Biotechnology Innovation Organization, ...
The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback